Notable 52-Week Highs and Lows of the Day 01/10: (GILD) (IDIX) (CIE) High; (HMA) (WBMD) Low

FREE Breaking News Alerts from StreetInsider.com!

Overall Analyst Rating:
BUY (= Flat)

Revenue Growth %: +9.1%

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:

Gilead Sciences Inc. (Nasdaq: GILD) high of $45.04. Could be seeing continued upside from the acquisition of Inhibitex (Nasdaq: INHX) by Bristol-Myers Squibb, as Gilead agreed to acquire Pharmasset (Nasdaq: VRUS) earlier in the year. Shares moved as much as 5.4 percent higher on the session.
Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) high of $11.72. Idenix moving higher again on rumors that Merck (NYSE: MRK) might make a bid. Nothing has been confirmed by Idenix or Merck. Also, Idenix is making a move higher following the Inhibitex acquisition, because regardless of what Merck does, Idenix has moved up the list on HVC treatment pharmas with takeover potential.
Cobalt International Energy, Inc. (NYSE: CIE) high of $19.00. Cobalt released a presentation to investors regarding its Cameia-1 discovery. Cobalt said there were "very encouraging results" at the well. To take a look at the presentation, click here.
Nuance Communications, Inc. (Nasdaq: NUAN) high of $28.61. Nuance almost always sees a little upside if Apple (Nasdaq: AAPL) moves higher, but the company also announced a strategic partnership with Gracenote on Tuesday. Shares are up 4.4 percent to the new high.

52-Week Low:

Health Management Associates Inc. (NYSE: HMA) low of $4.81. Down over 30 percent today, Health Management is lower following its fourth-quarter outlook; sees revs of $1.58 billion and EPS of 17 to 18 cents, versus consensus views calling for revs of $1.59 billion and EPS of 18 cents.

For 2012, its outlook calls for revs of $6.3 to $6.5 billion and earnings of 80 to 90 cents per share, versus views calling for revs of $6.54 billion and earnings of 81 cents per share.
WebMD Health Corp. (Nasdaq: WBMD) low of $25.01. WebMD lower after CEO Wayne Gattinella resigned and the company terminated discussions regarding a potential corporate transaction. The company also reaffirmed fourth-quarter guidance, but said 2012 is that revenue may be as much as 2 percent to 8 percent lower than 2011, with revenues declining more in the first half of the year and improving in the second half of the year. Shares fell 32 percent to the new mark Tuesday.

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!